Landscape of Glycolytic Metabolites and Their Regulating Proteins in Myocardium from Human Heart Failure with Preserved Ejection Fraction
Authors:
- 9 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 26 (9) , 1941-1951
Abstract
Aims: Heart failure (HF) with preserved ejection fraction (HFpEF) reflects half of all clinical HF yet has few therapies. Obesity and diabetes are now common comorbidities which have focused attention towards underlying myocardial metabolic defects. The profile of a major metabolic pathway, glycolytic intermediates and their regulating enzymes and ancillary pathways, remains unknown. Methods and results: Endomyocardial biopsies from HFpEF (n = 37) and non-failing controls (n = 21) were assayed by non-targeted or targeted metabolomics and immunoblot to determine glycolytic and ancillary pathway metabolites and protein expression of their regulating enzymes. Glucose and GLUT1 expression were higher in HFpEF, but prominent glycolytic metabolites: glucose-6-phosphate, fructose-1,6-biphosphate (F1,6bP), and 3-phosphoglycerate were reduced by −78%, −91%, and −73%, respectively, versus controls. Expression of their corresponding synthesizing enzymes hexokinase, phospho-fructokinase, and phosphoglycerate kinase were also significantly lower (all p < 0.0005). Pentose phosphate and hexosamine biosynthetic pathway metabolites were reduced while glycogen content increased. Despite proximal reduction in key glycolytic intermediates, pyruvate increased but mitochondrial pyruvate transporter (MPC1) expression was reduced. Pyruvate dehydrogenase converting pyruvate to acetyl-CoA was more activated but some Krebs cycle intermediates were reduced. This HFpEF glycolytic profile persisted after adjusting for body mass index (BMI), diabetes, age, and sex, or in subgroup analysis with controls and HFpEF matched for BMI and diabetes/insulin history. In HFpEF, BMI but not glycated haemoglobin negatively correlated with F1,6bP (p = 7e-5, r = −0.61) and phosphoenolpyruvate (p = 0.006, r = −0.46). Conclusions: Human HFpEF myocardium exhibits reduced glycolytic and ancillary pathway intermediates and expression of their synthesizing proteins. This combines features reported in HF with reduced ejection fraction and obesity/diabetes that likely exacerbate metabolic inflexibility.Keywords
Funding Information
- Division of Intramural Research (135827)
- Division of Intramural Research (166565)
- Division of Intramural Research (K23HL166770)
- Belfer Endowment
- American Health Assistance Foundation (23POST1026402)
- Amgen Inc
- Division of Intramural Research (R01AI156274)
- Division of Intramural Research (135827)
- Division of Intramural Research (166565)
- Division of Intramural Research (K23HL166770)
- Division of Intramural Research (R01AI156274)
This publication has 29 references indexed in Scilit:
- Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEFJACC: Basic To Translational Science, 2024
- Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection FractionThe Journal of Pharmacology and Experimental Therapeutics, 2023
- Heart Failure With Preserved Ejection FractionJACC, 2023
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection FractionNew England Journal of Medicine, 2022
- Comprehensive quantification of fuel use by the failing and nonfailing human heartScience, 2020
- In vivo [U-13C]glucose labeling to assess heart metabolism in murine models of pressure and volume overloadAmerican Journal of Physiology-Heart and Circulatory Physiology, 2020
- Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of CardiologyEuropean Heart Journal, 2018
- Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human HeartJACC: Basic To Translational Science, 2016
- Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS productionEMBO Molecular Medicine, 2012
- Glucose Deprivation Stimulates O-GlcNAc Modification of Proteins through Up-regulation of O-Linked N-AcetylglucosaminyltransferaseJournal of Biological Chemistry, 2008